Close menu
- Home
- Retail & Wholesale
-
Products & Suppliers
- Back to parent navigation item
- Products & Suppliers
-
Product Categories:
- Back to parent navigation item
- Product Categories:
- Alcoholic drinks
- Bakery
- Cereals & breakfast
- Cheese
- Chicken & poultry
- Chocolate
- Confectionery
- Crisps, nuts & snacks
- Dairy
- Fish
- Fresh produce
- Frozen
- Household
- Meat
- Own Label
- Sauces & condiments
- Seasonal
- Soft drinks
- Vaping
- Vegan & plant-based
- World foods
- Suppliers
- People
- Reports & Data
-
Topics A-Z
- Back to parent navigation item
- Topics A-Z
-
Popular topics:
- Back to parent navigation item
- Popular topics:
- Cost of living crisis
- Crime
- Deposit Return Schemes
- Finance
- Government & Regulation
- Health
- Inflation
- Loyalty
- Marketing
- Mergers & Acquisitions
- New Product Development
- Sourcing
- Supply chain
- Sustainability & environment
- Technology
- Ultra Processed Foods
- Vaping
- A-Z all topics
- Content by type:
- Events
- Ask iA (beta)
- Subscribe now
How is Big Food responding to the threat of GLP-1 drugs?
By Amir Mousavi2025-11-21T08:58:00
GLP-1 drugs could shrink global food volumes and rewrite the rules on how we eat, manufacture and market food, says Amir Mousavi, founder and food consultant at Good Food Studio
Originally developed for diabetes, GLP-1 drugs slow digestion, regulate blood sugar, and suppress appetite, transforming eating behaviour. As millions adopt the Mounjaro jab, food intake could fall sharply, a seismic shift for an industry built on volume.
Already have an account? Sign in here
Already have an account? Sign in here